Background: The FinnishIPF registry is a prospective, longitudinal national registry study on the epidemiology of idiopathic pulmonary fibrosis (IPF). It was designed to describe the characteristics, management and prognosis of prevalent and incident IPF patients. The study was initiated in 2012. Methods: We present here results limited to five university hospitals. Patients with IPF were screened from hospital registries using ICD-10 diagnosis codes J84.1 and J84.9. All patients who gave informed consent were included and evaluated using novel diagnostic criteria. Point prevalence on the 31st of December in 2012 was calculated using the reported population in each university hospital city as the denominator. Results: Patients with ICD-10 c...
Over the past decade, several large registries of patients with idiopathic pulmonary fibrosis (IPF) ...
Background: The early diagnosis of idiopathic pulmonary fibrosis (IPF) has become increasingly impor...
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dis...
Background: The FinnishIPF registry is a prospective, longitudinal national registry study on the ep...
BACKGROUND Idiopathic pulmonary fibrosis (IPF) differs substantially from other idiopathic inters...
Idiopathic pulmonary fibrosis (IPF) is characterised by unpredictable disease course and poor surviv...
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease (ILD) classified under id...
Introduction The previous data concerning the prevalence of idiopathic pulmonary fibrosis (IPF) and ...
Aim of the study: Potential care implications of antifibrotic reimbursement restrictions werestudied...
After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF) in 201...
International audienceRationale: Idiopathic pulmonary fibrosis (IPF) is a rare condition and few epi...
Over the past decade, several large registries of patients with idiopathic pulmonary fibrosis (IPF) ...
Background: The early diagnosis of idiopathic pulmonary fibrosis (IPF) has become increasingly impor...
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dis...
Background: The FinnishIPF registry is a prospective, longitudinal national registry study on the ep...
BACKGROUND Idiopathic pulmonary fibrosis (IPF) differs substantially from other idiopathic inters...
Idiopathic pulmonary fibrosis (IPF) is characterised by unpredictable disease course and poor surviv...
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease (ILD) classified under id...
Introduction The previous data concerning the prevalence of idiopathic pulmonary fibrosis (IPF) and ...
Aim of the study: Potential care implications of antifibrotic reimbursement restrictions werestudied...
After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF) in 201...
International audienceRationale: Idiopathic pulmonary fibrosis (IPF) is a rare condition and few epi...
Over the past decade, several large registries of patients with idiopathic pulmonary fibrosis (IPF) ...
Background: The early diagnosis of idiopathic pulmonary fibrosis (IPF) has become increasingly impor...
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dis...